HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $8,117,000 | -68.1% | 691,400 | -36.1% | 1.39% | -57.3% |
Q4 2019 | $25,407,000 | +25.9% | 1,081,159 | -0.9% | 3.25% | +6.5% |
Q3 2019 | $20,186,000 | -1.2% | 1,091,110 | -0.7% | 3.05% | +7.6% |
Q2 2019 | $20,425,000 | -24.9% | 1,098,723 | -1.3% | 2.84% | -19.8% |
Q1 2019 | $27,201,000 | +27.1% | 1,112,966 | +34.9% | 3.54% | +3.6% |
Q4 2018 | $21,407,000 | -18.8% | 825,269 | -0.9% | 3.41% | -19.8% |
Q3 2018 | $26,364,000 | -18.9% | 833,001 | -0.4% | 4.25% | -15.9% |
Q2 2018 | $32,507,000 | +148.9% | 836,737 | +76.8% | 5.06% | +76.5% |
Q1 2018 | $13,062,000 | +74.4% | 473,275 | +14.4% | 2.87% | +39.7% |
Q4 2017 | $7,488,000 | +17.8% | 413,721 | +5.1% | 2.05% | +2.0% |
Q3 2017 | $6,355,000 | +24.9% | 393,505 | +7.1% | 2.01% | +17.9% |
Q2 2017 | $5,088,000 | -6.7% | 367,390 | +1.0% | 1.71% | -18.1% |
Q1 2017 | $5,455,000 | – | 363,689 | – | 2.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |